Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine

Arthritis and Rheumatism

Volumn 42, Issue 8, 1999, Pages 1628-1634

  Tarkowski, Andrej ^a   Sun, Jia Bin ^a   Holmdahl, Rikard ^b   Holmgren, Jan ^a   Czerkinsky, Cecil ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLERA TOXIN B SUBUNIT; COLLAGEN TYPE 2; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; INTERLEUKIN 6; VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; BONE EROSION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; IMMUNOTHERAPY; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODY FORMATION; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHOLERA TOXIN; COLLAGEN; DISEASE PROGRESSION; IMMUNOTOXINS; MALE; MICE; MICE, INBRED DBA; VACCINES;

EID: 0033495868     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199908)42:8<1628::AID-ANR10>3.0.CO;2-T     Document Type: Article

References (27)

1. Trentham DF, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146: 857-67.
2. Stuart JM, Dixon FJ. Serum transfer of collagen-arthritis in mice. J Exp Med 1983;158:378-92.
3. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1998;18:335-43.
4. Thompson HSG, Staines NA. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 1986;64:581-6.
5. Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, and Thorbecke GJ. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A 1986;83:7443-6.
6. Hansson DG, Vaz NM, Rawlings LA, Lynch JM. Inhibition of specific immune responses by feeding protein antigens. II. Effects of prior passive and active immunization. J Immunol 1979;122: 2261-6.
7. Staines NA, Harper N, Ward FJ, Thompson HSG, Bansal S. Arthritis: animal models of oral tolerance. Ann N Y Acad Sci 1996;778:297-305.
8. Sun J-B, Holmgren J, Czerkinsky C. Cholera toxin B subunit: an effective transmucosal carrier delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci U S A 1994;91:10795-9.
9. Sun J-B, Rask C, Olsson T, Holmgren J, Czerkinsky C. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci U S A 1996;93:7196-201.
10. Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, et al. A cholera toxoid-insulin conjugate as oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci U S A 1997;94: 4610-4.
11. Miller EJ, Rhodes RK. Preparation and characterization of the different types of collagen. Methods Enzymol 1982;82:33-64.
12. Sanchez J, Holmgren J. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc Natl Acad Sci U S A 1989;86:481-5.
13. Czerkinsky C, Russell MW, Lycke N, Linkblad M, Holmgren J. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun 1989;57: 1072-7.
14. Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman WJ. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 1989; 32:1087-92.
15. Czerkinsky C, Moldoveanu Z, Mestecky J, Nilsson L-Å, Ouchterlony Ö. A novel two-colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J Immunol Methods 1988;115:31-8.
16. Czerkinsky C, Anderson G, Nilsson L-Å, Eckre H-P, Klareskog L, et al. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Detection of gamma interferon-secreting cells. J Immunol Methods 1988;110:29-36.
17. Sally R, Sarawar S, Doherty PC. Concurrent production of IL-2, IL-10, and gamma interferon in the regional lymph nodes of mice with Influenza pneumoniae. J Virol 1994;68:3112-9.
18. Czerkinsky C, Sun J-B, Lebens M, Li B-L, Rask C, Lindblad M, et al. Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of anti-infectious and anti-pathological immunity. Ann N Y Acad Sci 1996;778:185-93.
19. Staines NA, Harper N, Ward FJ, Malmström V, Holmdahl R, Bansal S. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine collagen type II collagen (CII) expressing a dominant T cell epitope. Clin Exp Immunol 1996;103:368-75.
20. Myers LK, Seyer JM, Stuart JM, Kang AH. Suppression of murine collagen-induced arthritis by nasal administration of collagen. Immunology 1997;90:161-4.
21. Lu S, Holmdahl R. Different therapeutic and bystander effects by intranasal administration of homologous type II and type IX collagens on the collagen-induced arthritis and pristane-induced arthritis in rats. Clin Immunol Immunopathol 1999;90:119-27.
22. Chen Y, Inobe J-I, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995;376:177-80.
23. Whitacre C, Gienapp C, Orosz IE, Bitar D. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991;147:2155-63.
24. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of TGF-β, IL-4 and PGE expression in the brain. J Exp Med 1992;176:1355-64.
25. Chen Y, Kuchroo VK, Inobe J-I, Haffler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-40.
26. Tamura S, Hatori E, Tsuruhara T, Aizawa C, Kurata T. Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heart-labile enterotoxin B subunit-conjugated ovalbumin. Vaccine 1997;15:225-9.
27. Williams NA, Stasiuk LM, Nashar TO, Richards CM, Lang AK, Day MJ, et al. Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A 1997;94:5290-5.